Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Neurodiagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The "Neurodiagnostics - Global Strategic Business Report" provides a comprehensive analysis of the global neurodiagnostics market across various geographic regions, including the USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East, and Africa. It offers insights into the market's recent past, current state, and future prospects.
The analysis encompasses different segments like diagnostic imaging systems, hospitals & surgery centers, neurology centers, and other end-uses, focusing on annual sales figures in US$ Million for the years 2022 through 2030 and the corresponding compound annual growth rates (CAGR).
The report presents a historic review from 2014 to 2021 and a 16-year perspective from 2014 to 2030, highlighting value sales breakdown by region and key segments. This information empowers stakeholders to make informed decisions based on the evolving dynamics in the global neurodiagnostics market.
Global Neurodiagnostics Market to Reach $13.7 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Neurodiagnostics estimated at US$7.5 Billion in the year 2022, is projected to reach a revised size of US$13.7 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2022-2030.
Diagnostic Imaging Systems, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the In-vitro diagnostics (IVD) segment is readjusted to a revised 7.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 12.3% CAGR
The Neurodiagnostics market in the U.S. is estimated at US$2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.
What's New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
A selection of companies mentioned in this report includes
- Advanced Brain Monitoring
- ANT Neuro
- Bio-Rad Laboratories
- Canon, Inc.
- DRG Instruments GmbH
- Elmiko Medical Sp. Z o.o.
- Fonar Corporation
- Fujifilm Holdings Corporation
- Fujirebio
- GE Healthcare
- Hitachi, Ltd.
- Hoffman-La Roche AG
- Lifelines Neuro Company, LLC
- Mitsar Co., Ltd.
- Motion Lab Systems, Inc.
- Natus Medical Incorporated
- Neusoft Medical Systems Co., Ltd.
- Nihon Kohden Corporation
- Philips Healthcare
- Qiagen N.V.
- Ridge Diagnostics
- Rigaku Corporation
- Siemens Healthineers
- Tecan Trading AG
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/kra5ai
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
